Current demands for standardization of Indian medicinal plants: A critical review

Q2 Medicine
Rishabh Kaundal , Dinesh Kumar
{"title":"Current demands for standardization of Indian medicinal plants: A critical review","authors":"Rishabh Kaundal ,&nbsp;Dinesh Kumar","doi":"10.1016/j.medidd.2025.100211","DOIUrl":null,"url":null,"abstract":"<div><div>The resurgence of interest in natural products and traditional medicines offers promising avenues for drug discovery. Medicinal plants’ novel chemical and molecular entities dominate current pharmaceutical research. India has mega biodiversity, including medicinal plants that contribute to drug development and health care via traditional practices. Due to the huge demand, a false practice, and quality issues have been observed in the market. Therefore, comprehensive information about standardization methods and processes are the need of hours to maintain quality of raw materials and final products. Thus, the current review insights the significant role of traditional medicines in India, where over 80<!--> <!-->% of the population relies on traditional and folklore practices for healthcare needs. This review also summarizes several standardization parameters, including stepwise pharmacognostic studies, WHO guidelines and official pharmacopeia standards. Published literature suggests that research on medicinal plants needs to be encouraged by governments through good policies, regulations, and trade standards of global market. The reviewed information will provide a foundation to develop monographs and quality parameters for Indian traditional drugs and herbal pharmacopoeia.</div></div>","PeriodicalId":33528,"journal":{"name":"Medicine in Drug Discovery","volume":"27 ","pages":"Article 100211"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine in Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590098625000089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The resurgence of interest in natural products and traditional medicines offers promising avenues for drug discovery. Medicinal plants’ novel chemical and molecular entities dominate current pharmaceutical research. India has mega biodiversity, including medicinal plants that contribute to drug development and health care via traditional practices. Due to the huge demand, a false practice, and quality issues have been observed in the market. Therefore, comprehensive information about standardization methods and processes are the need of hours to maintain quality of raw materials and final products. Thus, the current review insights the significant role of traditional medicines in India, where over 80 % of the population relies on traditional and folklore practices for healthcare needs. This review also summarizes several standardization parameters, including stepwise pharmacognostic studies, WHO guidelines and official pharmacopeia standards. Published literature suggests that research on medicinal plants needs to be encouraged by governments through good policies, regulations, and trade standards of global market. The reviewed information will provide a foundation to develop monographs and quality parameters for Indian traditional drugs and herbal pharmacopoeia.
印度药用植物标准化的当前需求:综述
对天然产物和传统药物兴趣的复苏为药物发现提供了有希望的途径。药用植物的新型化学和分子实体主导着当前的药物研究。印度拥有巨大的生物多样性,包括通过传统做法促进药物开发和医疗保健的药用植物。由于巨大的需求,市场上出现了错误的做法和质量问题。因此,关于标准化方法和过程的综合信息需要小时来保持原材料和最终产品的质量。因此,当前的综述洞察了传统药物在印度的重要作用,在印度,超过80%的人口依靠传统和民间习俗来满足医疗保健需求。本综述还总结了几种标准化参数,包括逐步生药学研究、世卫组织指南和官方药典标准。已发表的文献表明,各国政府需要通过良好的政策、法规和全球市场的贸易标准来鼓励药用植物的研究。这些信息将为制定印度传统药物和草药药典的专著和质量参数提供基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medicine in Drug Discovery
Medicine in Drug Discovery Medicine-Pharmacology (medical)
CiteScore
8.30
自引率
0.00%
发文量
30
审稿时长
21 days
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信